|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07F 9/12 | |
| A61K 31/661 | |||
| A61P 35/00 |
| (11) | Number of the document | 3298021 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16725997.7 |
| Date of filing the European patent application | 2016-05-18 | |
| (97) | Date of publication of the European application | 2018-03-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/033099 |
| Date | 2016-05-18 |
| (87) | Number | WO 2016/187316 |
| Date | 2016-11-24 |
| (30) | Number | Date | Country code |
| 201562163188 P | 2015-05-18 | US |
| (72) |
SIDDIQUI-JAIN, Adam, US
BEARSS, David, J., US
|
| (73) |
Tolero Pharmaceuticals, Inc.,
2975 W. Executive Parkway, Suite 320, Lehi, UT 84043,
US
|
| (54) | ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY |
| ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY |